Home › High Blood Pressure › Utah
High Blood Pressure clinical trials in Utah
8 studies for High Blood Pressure are looking for participants at sites in Utah.
Cities in Utah
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Ogden Clinic - Canyon View, Ogden
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07783802EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Olympus Family Medicine, Salt Lake City
- Velocity Clinical Research-West Jordan-69043, West Jordan
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07064473A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, South Salt Lake
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06742723: Vascular Function in Health and Disease
- University of Utah, Salt Lake City
RecruitingPhase 1Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT02966665THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
- St Marks Hospital, Salt Lake City
Recruiting
Ages 22 to 75 · All sexes · Updated Sep 24, 2026 · NCT06559891Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Bountiful
- Clinical Trial Site, Bountiful
- Clinical Trial Site, Layton
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07181109Global Paradise System US Post Approval Study
- St. Mark's Hospital, Salt Lake City
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT06297291Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
- Vanda Investigative Site, Salt Lake City
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Feb 27, 2026 · NCT07090161From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.